膀胱尿路上皮细胞焦亡在间质性膀胱炎发病机制及其病理生理表现中的研究进展

庞磊; 双卫兵

doi:10.13406/j.cnki.cyxb.003820

PDF(2716 KB)

重庆医科大学学报 ›› 2025, Vol. 50 ›› Issue (04) : 426-431. DOI: 10.13406/j.cnki.cyxb.003820

下尿路神经性排尿功能障碍及盆底功能修复专题

膀胱尿路上皮细胞焦亡在间质性膀胱炎发病机制及其病理生理表现中的研究进展

庞磊 ¹ ,
双卫兵 ²

作者信息 +

Research advances in the pathogenesis and pathophysiological manifestations of interstitial cystitis caused by urothelial cell pyroptosis

Pang Lei ¹ ,
Shuang Weibing ²

Author information +

History +

摘要

细胞焦亡是一种由炎症小体介导的、程序性的促炎症性细胞死亡方式，可以导致细胞内非活性细胞因子的激活以及消皮素D（gasdermin D，GSDMD）的裂解。炎症性膀胱疾病的主要病理结局是膀胱的顺应性丧失，而细胞焦亡在其过程中起到了重要的作用。一些研究发现，细胞焦亡受到DNA甲基化、线粒体DNA氧化损伤等机制的调控，从而干预间质性膀胱炎中膀胱尿路上皮细胞的生物学行为，从而诱发膀胱顺应性损伤。因此，通过概述间质性膀胱炎中细胞焦亡的调节机制以及焦亡在炎症性膀胱疾病中的潜在作用，以探索间质性膀胱炎的潜在诊断标志物，有助于间质性膀胱炎的预防和治疗。

Abstract

Pyroptosis is a proinflammatory form of regulated cell death that can lead to the activation of inactive cytokines and the cleavage of gasdermin D in cells. The main pathological outcome of inflammatory bladder disease is the loss of bladder compliance，and cell pyroptosis plays an important role in this process. Some studies have shown that cell pyroptosis is regulated by various mechanisms such as DNA methylation and mitochondrial DNA oxidative damage，which intervene in the biological behavior of bladder urothelial cells in interstitial cystitis and induce impairment of bladder compliance. Therefore，this article reviews the regulatory mechanisms of cell pyroptosis in interstitial cystitis and the potential role of pyroptosis in inflammatory bladder diseases，in order to explore potential diagnostic biomarkers for interstitial cystitis and facilitate the prevention and treatment of interstitial cystitis.

关键词

间质性膀胱炎 / 细胞焦亡 / DNA甲基化 / 线粒体氧化损伤

Key words

interstitial cystitis / pyroptosis / DNA methylation / mitochondrial oxidative damage

中图分类号

R69

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

庞磊 , 双卫兵. 膀胱尿路上皮细胞焦亡在间质性膀胱炎发病机制及其病理生理表现中的研究进展. 重庆医科大学学报. 2025, 50(04): 426-431 https://doi.org/10.13406/j.cnki.cyxb.003820

Pang Lei, Shuang Weibing. Research advances in the pathogenesis and pathophysiological manifestations of interstitial cystitis caused by urothelial cell pyroptosis[J]. Journal of Chongqing Medical University. 2025, 50(04): 426-431 https://doi.org/10.13406/j.cnki.cyxb.003820

参考文献

列表( 原文顺序 | 文献年度倒序 | 文中引用次数倒序 ) 可视化分析

1	Quentin Clemens J， Erickson DR， Varela NP，et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome[J]. J Urol，2022，208（1）：34-42. 本文引用 [1]

2	Li J， Yi X， Ai JZ. Broaden horizons：the advancement of interstitial cystitis/bladder pain syndrome[J]. Int J Mol Sci，2022，23（23）：14594. 本文引用 [1]

3	Gracely A， Cameron AP. Managing interstitial cystitis/bladder pain syndrome in older adults[J]. Drugs Aging，2021，38（1）：1-16. 本文引用 [1]

4	Masterson JM， Castañeda PR， Kim J. Pathophysiology and clinical biomarkers in interstitial cystitis[J]. Urol Clin North Am，2023，50（1）：39-52. 本文引用 [1]

5	Chen A， Shahiyan RH， Anger JT. Interstitial cystitis/bladder pain syndrome treatment：a systematic review of sexual health outcomes[J]. Sex Med Rev，2022，10（1）：71-76. 本文引用 [1]

6	Su F， Zhang W， Meng LF，et al. Multimodal single-cell analyses outline the immune microenvironment and therapeutic effectors of interstitial cystitis/bladder pain syndrome[J]. Adv Sci，2022，9（18）：e2106063. 本文引用 [1]

7	Mohammad A， Laboulaye MA， Shenhar C，et al. Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome[J]. Nat Rev Urol，2024，21（7）：433-449. 本文引用 [1]

8	Moody CC， Fashokun TB. Painful bladder syndrome/interstitial cystitis and high tone pelvic floor dysfunction[J]. Obstet Gynecol Clin North Am，2021，48（3）：585-597. 本文引用 [1]

9	Bhide A， Tailor V， Khullar V. Interstitial cystitis/bladder pain syndrome and recurrent urinary tract infection and the potential role of the urinary microbiome[J]. Post Reprod Health，2020，26（2）：87-90. 本文引用 [1]

10	Beltran E. Female pelvic conditions：interstitial cystitis/bladder pain syndrome[J]. FP Essent，2024，547：33-39. 本文引用 [1]

11	Donohoo N， Orlando A， Chai TC. Interstitial cystitis/bladder pain syndrome is imprecise：time to cleave into interstitial cystitis and bladder pain syndrome as separate conditions[J]. J Urol，2024，212（1）：223-224. 本文引用 [1]

12	Tornic J， Engeler D. Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis[J]. Curr Opin Urol，2024，34（2）：84-88. 本文引用 [1]

13	Jones E， Palmieri C， Thompson M，et al. Feline idiopathic cystitis：pathogenesis，histopathology and comparative potential[J]. J Comp Pathol，2021，185：18-29. 本文引用 [1]

14	Kendall HJ， Schrijvers J， Heesakkers JPFA. Current position of neuromodulation for bladder pain syndrome/interstitial cystitis[J]. Curr Opin Urol，2024，34（2）：64-68. 本文引用 [1]

15	Kirkham A， Swainston K. Women’s experiences of interstitial cystitis/painful bladder syndrome[J]. West J Nurs Res，2022，44（2）：125-132. 本文引用 [1]

16	Sutherland S， Grace Kelly A， McKernan LC，et al. Coping with interstitial cystitis/bladder pain syndrome[J]. Neurourol Urodyn，2024，43（8）：1895-1902. 本文引用 [1]

17	Yu J， Lee CU， Lee KS，et al. Optimal endoscopic treatment and partial cystectomy with or without bladder augmentation for Hunner-type interstitial cystitis[J]. Low Urin Tract Symptoms，2023，15（6）：216-224. 本文引用 [1]

18	Mishra NN. Interstitial cystitis/bladder pain syndrome（IC/BPS）：Single-center 20 year experience and treatment results in India[J]. Neurourol Urodyn，2022，41（6）：1390-1398. 本文引用 [1]

19	Dobberfuhl AD. Pathophysiology，assessment，and treatment of overactive bladder symptoms in patients with interstitial cystitis/bladder pain syndrome[J]. Neurourol Urodyn，2022，41（8）：1958-1966. 本文引用 [1]

20	Osman NI， Bratt DG， Downey AP，et al. A systematic review of surgical interventions for the treatment of bladder pain syndrome/interstitial cystitis[J]. Eur Urol Focus，2021，7（4）：877-885. 本文引用 [1]

21	van Ginkel C， Hurst RE， Janssen D. The urothelial barrier in interstitial cystitis/bladder pain syndrome：its form and function，an overview of preclinical models[J]. Curr Opin Urol，2024，34（2）：77-83. 本文引用 [1]

22	Dayem AA， Song K， Lee S，et al. New therapeutic approach with extracellular vesicles from stem cells for interstitial cystitis/bladder pain syndrome[J]. BMB Rep，2022，55（5）：205-212. 本文引用 [1]

23	Taneja R， Pandey S， Priyadarshi S，et al. Diagnostic and therapeutic cystoscopy in bladder pain syndrome/interstitial cystitis：systematic review of literature and consensus on methodology[J]. Int Urogynecol J，2023，34（6）：1165-1173. 本文引用 [1]

24	Taneja R， Pandey S， Priyadarshi S，et al. Diagnostic and therapeutic cystoscopy in bladder pain syndrome/interstitial cystitis：systematic review of literature and consensus on methodology[J]. Int Urogynecol J，2023，34（6）：1165-1173. 本文引用 [1]

25	Yu WR， Kuo HC. Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in[J]. Low Urin Tract Symptoms，2024，16（1）：e12508. 本文引用 [2]

26	Pires MV， de Lima CJ， Carvalho HC，et al. Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary-Sant symptom index[J]. Int Urogynecol J，2023，34（7）：1437-1446. 本文引用 [1]

27	Hellman KM， Datta A， Steiner ND，et al. Identiﬁcation of experimental bladder sensitivity among dysmenorrhea sufferers[J]. Am J Obstet Gynecol，2018，219（1）：112-132. 本文引用 [1]

28	Lai JY， Liu X， Su HW，et al. Emodin inhibits bladder inflammation and fibrosis in mice with interstitial cystitis by regulating JMJD3[J]. Acta Cir Bras，2023，38：e385123. 本文引用 [1]

29	Torimoto K， Ueda T， Kasahara M，et al. Identification of diagnostic serum biomarkers for Hunner-type interstitial cystitis[J]. Low Urin Tract Symptoms，2022，14（5）：334-340. 本文引用 [2]

30	Neale A， Malik N， Taylor C，et al. Bladder pain syndrome/interstitial cystitis in contemporary UK practice：Outcomes of phenotype-directed management[J]. LUTS Low Urin Tract Symptoms，2021，13（1）：123-128. 本文引用 [2]

基金

国家自然科学基金项目面上资助项目(82470809)

山西省自然科学基金面上资助项目(202103021224391)

PDF(2716 KB)

Accesses

Citation

Detail

段落导航

Received	Published
2024-11-28	2025-04-28
Issue Date
2025-05-19

选择文件类型/文献管理软件名称

选择包含的内容